Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Ellen Braat

doi:10.1016/j.eururo.2010.07.016

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Ellen Braat

Urology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	632-633
Number of pages	2
Journal	European Urology
Volume	58
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2010.07.016
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2010.07.016

http://hdl.handle.net/1765/27943

Cite this

@article{e498313d05a641bda16a32bfac2db618,

title = "Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer",

author = "Ellen Braat",

year = "2010",

doi = "10.1016/j.eururo.2010.07.016",

language = "Undefined/Unknown",

volume = "58",

pages = "632--633",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

AU - Braat, Ellen

PY - 2010

Y1 - 2010

U2 - 10.1016/j.eururo.2010.07.016

DO - 10.1016/j.eururo.2010.07.016

M3 - Article

VL - 58

SP - 632

EP - 633

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -